<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR456.html">Part 456
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  456.702  Definitions.
                            </h3>
                            <p class="depth0">For purposes of this subpart--</p><p class="depth0">Abuse is defined as in Sec.  455.2 of this chapter.</p><p class="depth0">Adverse medical result means a clinically significant undesirable  effect, experienced by a patient, due to a course of drug therapy.</p><p class="depth0">Appropriate and medically necessary means drug prescribing and  dispensing that is in conformity with the predetermined standards  established in accordance with Sec.  456.703.</p><p class="depth0">Criteria is defined as in Sec.  466.1 of this chapter.</p><p class="depth0">Fraud is defined as in Sec.  455.2 of this chapter.</p><p class="depth0">Gross overuse means repetitive overutilization without therapeutic  benefit.</p><p class="depth0">Inappropriate and medically unnecessary means drug prescribing and  dispensing not in conformity with the definition of appropriate and  medically necessary.</p><p class="depth0">Overutilization means use of a drug in a quantity, strength, or  duration that is greater than necessary to achieve a desired therapeutic  goal or that puts the beneficiary at risk of a clinically significant  undesirable effect, or both.</p><p class="depth0">Predetermined standards means criteria and standards that have been  established in accordance with the requirements of Sec.  456.703.</p><p class="depth0">Standards is defined as in Sec.  466.1 of this chapter.</p><p class="depth0">Underutilization means use of a drug by a beneficiary in  insufficient quantity, strength, or duration to achieve a desired  therapeutic goal or that puts the beneficiary at risk of a clinically  significant undesired effect, or both.  [57 FR 49408, Nov. 2, 1992, as amended at 59 FR 48824, Sept. 23, 1994]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
